<?xml version="1.0" encoding="UTF-8"?>
<ref id="B58-marinedrugs-17-00373">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Onari</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yokoyama</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Haruta</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Nakashima</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Iwamoto</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Hattori</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Kohno</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>IL-12p40 is essential for the down-regulation of airway hyperresponsiveness in a mouse model of bronchial asthma with prolonged antigen exposure</article-title>
  <source>Clin. Exp. Allergy</source>
  <year>2009</year>
  <volume>39</volume>
  <fpage>290</fpage>
  <lpage>298</lpage>
  <pub-id pub-id-type="doi">10.1111/j.1365-2222.2008.03131.x</pub-id>
  <pub-id pub-id-type="pmid">19032358</pub-id>
 </element-citation>
</ref>
